# OnCo record ixabepilone (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ixabepilone/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ixabepilone" ;
  schema:name "Ixabepilone"@en ;
  schema:description "Ixabepilone (Ixempra) is a chemotherapy infusion for breast cancer that has stopped responding to anthracyclines, taxanes and capecitabine."@en ;
  schema:url <https://onco.cc/drugs/ixabepilone/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Ixabepilone> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=ixabepilone>, <https://www.cancer.gov/about-cancer/treatment/drugs/ixabepilone> ;
  onco:status "approved" ;
  onco:tag "nci-list" ;
  onco:modality "Epothilone B analogue (microtubule stabiliser)" ;
  schema:alternateName "Ixempra" ;
  onco:approval "US 2007: Metastatic or locally advanced breast cancer after anthracycline and taxane (with capecitabine) or after anthracycline, taxane and capecitabine (monotherapy)" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/tnbc/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:companies <https://onco.cc/companies/bms/> ;
  onco:trials <https://onco.cc/trials/nct00630032/>, <https://onco.cc/trials/nct00883116/>, <https://onco.cc/trials/nct00998738/> .